Health Care · Laboratory Analytical Instruments

AVTR Avantor Inc SEC Filings & Insider Trading Activity 2026

company
CIK 172248275 filings

AVTR at a glance

Avantor Inc (AVTR, SEC CIK 1722482) filed its latest 10-K annual report on February 11, 2026, a 10-Q quarterly report on October 28, 2026, an 8-K current report on November 3, 2026 and Form 4 insider filings as recently as November 12, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), Avantor Inc (AVTR) reported revenue of $6.6 billion (down 3.4% from FY2024) and a net loss of $530.2 million. Diluted EPS was -$0.78.
  • As of September 30, 2026, 35 institutional investment managers tracked by SignalX reported holding Avantor Inc (AVTR) shares worth $3.9 billion in 13F-HR filings.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$6.6B
−3.4% vs prior year
Insiders · 90 days
0 buys · 0 sells
No open-market trades
13F holders
35 funds
$3.9B · +0 vs prior quarter
Latest 8-K
Nov 3, 2026
Item 5.02

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • New risk: VWR Distribution goodwill impairment, triggered by sustained share-price and market-capitalization decline in Q1 2026
  • Valuation risk: Fair value exceeded carrying value by a limited margin, despite no impairment recorded
  • Market risk: Adverse changes in operating performance, forecasted cash flows, discount rates, or market conditions could reduce valuation
  • Financial reporting risk: Future goodwill impairment could produce a material non-cash charge

Management Discussion & Analysis

  • Revenue $1,698.3M, up 4.6% YoY from $1,623.8M, including 5.2% organic growth
  • Gross margin 31.5% vs 32.4% YoY; Adjusted EBITDA margin 15.1% vs 16.5%
  • Best segment VWR Distribution sales $1,233.8M, up 5.0%; worst Adjusted Operating Income $119.4M, down $12.6M
  • Operating cash flow $195.1M; quarter-end cash $464.3M; $425.0M remaining under stock repurchase authorization
  • Headwinds: inflation, currency volatility, trade-policy uncertainty, and VWR goodwill impairment sensitivity

AI summary of the AVTR 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 3, 2026Full analysis →

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • Special retention and performance award for Chief Legal Officer Claudius Sokenu, signaling importance of his litigation and regulatory leadership
  • 62,305 restricted stock units granted October 31, 2026 under Avantor’s 2019 Equity Incentive Plan
Filed Oct 28, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q3 2026 results released for quarter ended September 30, 2026
  • Exhibit 99.1 contains the substantive financial results and management commentary

Item EX-99.1: Item EX-99.1

  • Q3 net sales $1,698.3M, up 4.6% reported and 5.2% organically, marking a return to year-over-year growth
  • Adjusted EPS $0.22 matched prior year, while adjusted EBITDA margin fell to 15.1% from 16.5%
Filed Sep 21, 2026Full analysis →

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • Todd Garner appointed Avantor CFO on September 21, 2026, replacing interim CFO Steven Eck
  • Garner brings prior CFO experience at CONMED and joins Avantor’s Executive Leadership Team

Item 7.01: Regulation FD Disclosure

  • Press release announces Mr. Garner’s appointment, signaling a leadership or governance change
  • Investor significance depends on Mr. Garner’s role, responsibilities and compensation detailed in Exhibit 99.1

Item EX-99.1: Item EX-99.1

  • Todd Garner appointed Executive Vice President and CFO effective September 21, 2026
  • Finance oversight includes planning, accounting, treasury, tax, investor relations and internal audit

AI summaries of AVTR 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for AVTR

Don't miss the next AVTR filing

  • Alerts as it files. A push when AVTR files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut AVTR, by share count.
  • Ask anything. An AI agent that reads every AVTR filing and answers with sources.

AVTR alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Blenn MaryFNov 10, 2026$15.57
Sokenu ClaudiusAOct 30, 2026-
Hankamer BrittanyAOct 30, 2026-
Garner Todd WASep 21, 2026-
Garner Todd WASep 21, 2026-
Ligner EmmanuelFAug 18, 2026$13.33
Hankamer BrittanyFAug 14, 2026$13.66
Eck Steven WFJul 31, 2026$13.78

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$6.8B$6.6B
Gross Profit-$2.3B$2.1B
Operating Income-$1.1B-$246.2M
Net Income-$711.5M-$530.2M
Gross Margin-33.6%32.7%
Op. Margin-16.0%-3.8%
Net Margin-10.5%-8.1%
Balance Sheet
Total Assets$13.0B$12.1B$11.8B
Equity-$6.0B$5.6B
ROE-11.9%-9.5%
Per Share
EPS-$1.04$-0.78
Cash Flow
Operating CF-$840.8M$623.8M
CapEx$146.4M$148.8M$128.8M

Source: XBRL data in Avantor Inc (AVTR)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate AVTR share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
AVTR shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202635$3.87B
Q2 202635$2.65B
Q1 202634$1.89B
Q4 202533$2.84B
Q3 202535$3.02B
Q2 202533$3.30B
Q1 202530$2.43B
Q4 202427$2.82B
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
New Positions
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 262 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

AVTR filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 12, 2026--
8-KNov 3, 2026Analysis-
4Nov 3, 2026--
4Nov 3, 2026--
10-QOct 28, 2026Analysis
8-KOct 28, 2026Analysis-
4Sep 23, 2026--
8-KSep 21, 2026Analysis-
8-KSep 21, 2026Analysis-
8-KAug 27, 2026Analysis-
4Aug 20, 2026--
4Aug 18, 2026--
4Aug 4, 2026--
8-KJul 29, 2026Analysis-
10-QJul 29, 2026-
4Jul 27, 2026--
8-KJul 17, 2026Analysis-
4Jun 22, 2026--
8-KMay 12, 2026-
4May 11, 2026-
4May 11, 2026-
4May 11, 2026-
4May 11, 2026-
4May 11, 2026-
4May 11, 2026-

Related Health Care companies

All Health Care →

AVTR SEC filings: frequently asked questions

Which institutions hold AVTR stock?

As of September 30, 2026, the largest Avantor Inc (AVTR) holders among the 13F filers tracked by SignalX were BlackRock ($1.1 billion), Vanguard Portfolio Management LLC ($471.2 million), Vanguard Capital Management LLC ($457.1 million), Dimensional Fund Advisors ($372.6 million), State Street Corp ($323.8 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was AVTR's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), Avantor Inc (AVTR) reported revenue of $6.6 billion (down 3.4% from FY2024) and a net loss of $530.2 million. Diluted EPS was -$0.78. The figures come from the XBRL data in the 10-K.

What did AVTR report in its latest 8-K?

Avantor Inc (AVTR) filed an 8-K on November 3, 2026 reporting Item 5.02 (Departure/Appointment of Directors or Principal Officers). Special retention and performance award for Chief Legal Officer Claudius Sokenu, signaling importance of his litigation and regulatory leadership.

What are the latest AVTR SEC filings?

Avantor Inc (AVTR) filed its latest 10-K annual report on February 11, 2026, a 10-Q quarterly report on October 28, 2026, an 8-K current report on November 3, 2026 and a Form 4 insider filing on November 12, 2026.

What is AVTR's SEC CIK number?

Avantor Inc (AVTR)'s SEC Central Index Key (CIK) is 1722482. EDGAR lists every AVTR filing under that number.

Ask anything about AVTR

The research agent reads AVTR's filings, financials, insider trades and 13F holders, then answers with sources.